Source:http://linkedlifedata.com/resource/pubmed/id/10068661
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1999-3-30
|
| pubmed:abstractText |
We evaluated the capacity of adeno-associated virus (AAV) vectors to transduce primitive human myeloid progenitor cells derived from marrow and cord blood in long-term cultures and long-term culture-initiating cell (LTC-IC) assays. Single-colony analyses showed that AAV vectors transduced CD34(+) and CD34(+)38(-) clonogenic cells in long-term culture. Gene transfer was readily observed in LTC-ICs derived from 5-, 8-, and 10-week cultures. Recombinant AAV (rAAV) transduction was observed in every donor analyzed, although a wide range of gene transfer frequencies (5% to 100%) was noted. AAV transduction of LTC-ICs was stable, with week-8 and -10 LTC-ICs showing comparable or better transduction relative to week-5 LTC-ICs. Fluorescence in situ hybridization (FISH) analyses performed to determine the fate of AAV vectors in transduced cells showed that 9% to 28% of CD34(+) and CD34(+)38(-) cells showed stable vector integration as evidenced by chromosome-associated signals in metaphase spreads. Comparisons of interphase and metaphase FISH suggested that a fraction of cells also contained episomal vector at early time points after transduction. Despite the apparent loss of the episomal forms with continued culture, the number of metaphases containing integrated vector genomes remained stable long term. Transgene transcription and placental alkaline phosphatase (PLAP) expression was observed in CD34(+), CD34(+)38(-) LTC-ICs in the absence of selective pressure. These results suggest that primitive myeloid progenitors are amenable to genetic modification with AAV vectors.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0006-4971
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
93
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1882-94
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:10068661-Alkaline Phosphatase,
pubmed-meshheading:10068661-Antigens, CD34,
pubmed-meshheading:10068661-Bone Marrow Cells,
pubmed-meshheading:10068661-Cells, Cultured,
pubmed-meshheading:10068661-Dependovirus,
pubmed-meshheading:10068661-Gene Expression,
pubmed-meshheading:10068661-Gene Transfer Techniques,
pubmed-meshheading:10068661-Genetic Vectors,
pubmed-meshheading:10068661-Granulocytes,
pubmed-meshheading:10068661-HIV Long Terminal Repeat,
pubmed-meshheading:10068661-Hematopoietic Stem Cells,
pubmed-meshheading:10068661-Humans,
pubmed-meshheading:10068661-In Situ Hybridization, Fluorescence,
pubmed-meshheading:10068661-Macrophages,
pubmed-meshheading:10068661-Placenta,
pubmed-meshheading:10068661-RNA, Antisense,
pubmed-meshheading:10068661-Time Factors,
pubmed-meshheading:10068661-Transcription, Genetic
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors.
|
| pubmed:affiliation |
Division of Pediatrics, Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA, USA. schatterjee@coh.org
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|